Philip Liebson to Humans
This is a "connection" page, showing publications Philip Liebson has written about Humans.
Connection Strength
0.339
-
Stem-cell angiogenesis and regeneration of the heart: review of a saga of 2 decades. Clin Cardiol. 2015 May; 38(5):309-16.
Score: 0.028
-
Cardiovascular disease in special populations III: stroke. Prev Cardiol. 2010; 13(1):1-7.
Score: 0.019
-
Cardiovascular risk in special populations IV: Congenital heart defects. Prev Cardiol. 2010; 13(2):49-55.
Score: 0.019
-
Ongoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial (ONTARGET): implications for reduced cardiovascular risk. Prev Cardiol. 2009; 12(1):43-50.
Score: 0.018
-
Cardiovascular risk in special populations: overview. Prev Cardiol. 2009; 12(3):121-7.
Score: 0.018
-
Cardiovascular risk in special populations II: hypertension. Prev Cardiol. 2009; 12(4):189-97.
Score: 0.018
-
ENHANCE and ONTARGET. Prev Cardiol. 2008; 11(3):179-82.
Score: 0.017
-
Calcium channel blockers in the spectrum of antihypertensive agents. Expert Opin Pharmacother. 2006 Dec; 7(17):2385-401.
Score: 0.016
-
Muraglitazar and the FDA: what constitutes drug safety? Prev Cardiol. 2006; 9(2):110-4.
Score: 0.015
-
VALIANT and EUROPA. Prev Cardiol. 2004; 7(1):42-4.
Score: 0.013
-
VISP and INVEST. Prev Cardiol. 2004; 7(2):93-6.
Score: 0.013
-
ALLHAT and AFFIRM. Prev Cardiol. 2003; 6(1):54-60.
Score: 0.012
-
LIFE and ARBITER. Prev Cardiol. 2003; 6(2):108-11.
Score: 0.012
-
AVID and COMET. Prev Cardiol. 2003; 6(4):218-20.
Score: 0.012
-
ASAP and ANTIBIO. Prev Cardiol. 2003; 6(3):166-8.
Score: 0.012
-
Transesophageal echocardiography in critically ill patients: what is the intensivist's role? Crit Care Med. 2002 May; 30(5):1165-6.
Score: 0.011
-
Development and Validation of Risk Prediction Models for Cardiovascular Events in Black Adults: The Jackson Heart Study Cohort. JAMA Cardiol. 2016 04 01; 1(1):15-25.
Score: 0.007
-
Relations between subclinical disease markers and type 2 diabetes, metabolic syndrome, and incident cardiovascular disease: the Jackson Heart Study. Diabetes Care. 2015 Jun; 38(6):1082-8.
Score: 0.007
-
Clinical correlates and prognostic significance of change in standardized left ventricular mass in a community-based cohort of African Americans. J Am Heart Assoc. 2015 Feb 05; 4(2).
Score: 0.007
-
2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014 Dec 23; 130(25):e344-426.
Score: 0.007
-
2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014 Dec 23; 130(25):2354-94.
Score: 0.007
-
2014 AHA/ACC Guideline for the Management of Patients with Non-ST-Elevation Acute Coronary Syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2014 Dec 23; 64(24):e139-e228.
Score: 0.007
-
The relation of diabetes, impaired fasting blood glucose, and insulin resistance to left ventricular structure and function in African Americans: the Jackson Heart Study. Diabetes Care. 2011 Feb; 34(2):507-9.
Score: 0.005
-
Distribution and determinants of Doppler-derived diastolic flow indices in African Americans: the Jackson Heart Study (JHS). Am Heart J. 2009 Aug; 158(2):209-16.
Score: 0.005
-
Diabetes, gender, and left ventricular structure in African-Americans: the atherosclerosis risk in communities study. Cardiovasc Ultrasound. 2006 Nov 08; 4:43.
Score: 0.004
-
Left ventricular mass indexed to height and prevalent MRI cerebrovascular disease in an African American cohort: the Atherosclerotic Risk in Communities study. Stroke. 2005 Mar; 36(3):546-50.
Score: 0.003
-
Comparison of the prognostic value of left ventricular hypertrophy in African-American men versus women. Am J Cardiol. 2004 Dec 01; 94(11):1383-90.
Score: 0.003
-
Optimal threshold value for left ventricular hypertrophy in blacks: the Atherosclerosis Risk in Communities study. Hypertension. 2005 Jan; 45(1):58-63.
Score: 0.003
-
Hormone therapy and selective estrogen receptor modulators for prevention of coronary heart disease in postmenopausal women estrogen replacement from the cardiologist's perspective. Cardiol Rev. 2004 Nov-Dec; 12(6):287-98.
Score: 0.003
-
Role of surrogate markers in assessing patients with diabetes mellitus and the metabolic syndrome and in evaluating lipid-lowering therapy. Am J Cardiol. 2004 Jun 03; 93(11A):32C-48C.
Score: 0.003
-
Effect of contrast enhancement on measurement of carotid artery intimal medial thickness. Vasc Med. 2004 Feb; 9(1):7-12.
Score: 0.003
-
Left ventricular structure and systolic function in African Americans: the Atherosclerosis Risk in Communities (ARIC) study. Ethn Dis. 2004; 14(4):483-8.
Score: 0.003
-
Comparison of m-mode echocardiographic left ventricular mass measured using digital and strip chart readings: the Atherosclerosis Risk in Communities (ARIC) study. Cardiovasc Ultrasound. 2003 Jun 27; 1:8.
Score: 0.003
-
Risk stratification post-myocardial infarction: is early coronary angiography the more effective strategy? Prog Cardiovasc Dis. 2002 Jul-Aug; 45(1):49-66.
Score: 0.003